skip to content

Roche’s Half-Year Results 2023

Roche has published its Half-Year Results for 2023 prior to the opening of the Swiss Stock Exchange on Thursday, 27 July 2023.

Agenda
OverviewThomas Schinecker, CEO Roche Group
Pharmaceuticals Division Teresa Graham, CEO Roche Pharmaceuticals
Diagnostics DivisionMatt Sause, CEO Roche Diagnostics
Financial ResultsAlan Hippe, Chief Financial and IT Officer
Questions and answersBruno Eschli, Head of Investor Relations

Webinar Replay

Investors

Past IR Events
View more Events